Bank Central Asia Tbk vs Hetzer Medical Indonesia Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,375 (market cap 774.97T, 83.21M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp73 (market cap 109.38B, 60.43M 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 7085.1× Hetzer Medical Indonesia Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (83.21M versus 60.43M). Which is the better fit depends on your goals.
| BBCA | MEDS | |
|---|---|---|
Market Cap | 774.97T | 109.38B |
Volume | 83.21M | 60.43M |
Lot | 832.08K | 604.35K |
Turnover | 526.91B | 4.46B |
Average Price | 6,332.47 | 73.8 |
Value | 526.91B | 4.46B |
Indicative Equilibrium Price | 6,375 | 73 |
Indicative Equilibrium Volume | 417.93K | 12.68K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →